Douglas Jermasek - 21 Nov 2022 Form 4 Insider Report for Unicycive Therapeutics, Inc. (UNCY)

Role
EVP of Corporate Strategy
Signature
/s/ Doug Jermasek
Issuer symbol
UNCY
Transactions as of
21 Nov 2022
Net transactions value
$0
Form type
4
Filing time
23 Nov 2022, 07:00:20 UTC
Previous filing
21 Nov 2022
Next filing
09 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UNCY Stock Options Award $0 +55,000 +55% $0.000000 155,000 21 Nov 2022 Common Stock 55,000 $0.7500 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 13,750 of the stock options vest on first anniversary of the date of grant and 1/36th of the remaining options vest at the end of each successive month thereafter.